383 related articles for article (PubMed ID: 16751138)
1. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
[TBL] [Abstract][Full Text] [Related]
2. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
3. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing.
Favaloro EJ; Soltani S; McDonald J
Am J Clin Pathol; 2004 Nov; 122(5):686-92. PubMed ID: 15491964
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
5. Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming.
Refaai MA; Lukoszyk M; Hughes J; Eby CS; Van Cott EM
Am J Clin Pathol; 2005 Dec; 124(6):972; author reply 973. PubMed ID: 16416745
[No Abstract] [Full Text] [Related]
6. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature.
Zürcher M; Sulzer I; Barizzi G; Lämmle B; Alberio L
Thromb Haemost; 2008 Feb; 99(2):416-26. PubMed ID: 18278194
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
8. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight.
Cardigan R; Lawrie AS; Mackie IJ; Williamson LM
Transfusion; 2005 Aug; 45(8):1342-8. PubMed ID: 16078924
[TBL] [Abstract][Full Text] [Related]
9. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
11. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years.
Nilsson TK; Boman K; Jansson JH; Thøgersen AM; Berggren M; Broberg A; Granlund A
Thromb Res; 2005; 116(3):249-54. PubMed ID: 15935834
[TBL] [Abstract][Full Text] [Related]
12. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
[TBL] [Abstract][Full Text] [Related]
13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
15. [Functionality of von Willebrand factor present in Fanhdi: adhesion to the vascular subendothelium in vitro].
Escolar G; Viñas M; Pino M; Casamiquela R; Jorquera JI
Sangre (Barc); 1997 Oct; 42(5):377-81. PubMed ID: 9424737
[TBL] [Abstract][Full Text] [Related]
16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V
Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
[TBL] [Abstract][Full Text] [Related]
18. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
19. Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures.
Lamboo M; Poland DC; Eikenboom JC; Harvey MS; Groot E; Brand A; de Vries RR
Transfus Med; 2007 Jun; 17(3):182-6. PubMed ID: 17561859
[TBL] [Abstract][Full Text] [Related]
20. Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood.
Solheim BG; Bergerud UE; Kjeldsen-Kragh J; Brosstad F; Mollnes TE; Högman CF; Eriksson L; Schutz R
Vox Sang; 1998; 74(3):168-75. PubMed ID: 9595644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
